Prevalensi Rinosinusitis Kronik di Poliklinik THT-KL Rumah Sakit Universitas Kristen Indonesia Periode 2018-2021

Marbun, Arie Sumbaga Agung (2022) Prevalensi Rinosinusitis Kronik di Poliklinik THT-KL Rumah Sakit Universitas Kristen Indonesia Periode 2018-2021. S1 thesis, Universitas Kristen Indonesia.

	Text (Hal_Judul_Daftar_Isi_Daftar_Tabel_Daftar_Gambar_Daftar_Singkatan_Daftar_Lampiran_Abstrak) HalJudulAbstrakDaftarisiDaftarGambarDaftarTabelLampiran.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (3MB)
	Text (BAB_I) BABI.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (370kB)
	Text (BAB_II) BABII.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (1MB)
	Text (BAB_III) BABIII.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (364kB)
	Text (BAB_IV) BABIV.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (357kB)
	Text (BAB_V) BABV.pdf Restricted to Registered users only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (335kB)
	Text (Daftar_Pustaka) DaftarPustaka.pdf Available under License Creative Commons Attribution Non-commercial Share Alike. Download (343kB)
	Text (Lampiran) Lampiran.pdf Restricted to Repository staff only Available under License Creative Commons Attribution Non-commercial Share Alike. Download (1MB)

Abstract

Rinosinusitis kronik merupakan peradangan di hidung dan paranasal sinus yang berlangsung setidaknya 8 – 12 minggu dengan lebih dari 2 gejala yang menyertai seperti hidung tersumbat/kongesti/obstruksi, sekret pada hidung (drip hidung anterior atau posterior), nyeri pada wajah/tekanan dan pengurangan atau kehilangan penciuman serta tanda endoskopi penyakit atau perubahan Computerised Tomography Scan (CT Scan) yang relevan. Menurut Global Alergi and European Network project (GA2LEN) pervalensi keseluruhan RSK menurut kriteria European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) adalah 10,9% dikatikan dengan asma khusunya onset lambat. Beberapa penelitian lain juga dilakukan CRS. A survey di USA memperkirakan sekitar 16% dari populasi terdampak oleh RSK. Tujuan penelitian untuk mengetahui prevalensi rinosinusitis kronik di Poliklinik THT-KL Rumah Sakit Universitas Kristen Indonesia Jakarta Periode 2018-2021. Penelitian ini menggunakan metode deskriptif dengan desain retrospektif pada 30 pasien. Hasilnya mayoritas pasien pada kelompok usia 30 – 39 tahun 30 %, jenis kelamin wanita 56.7% dan pria 43.3%. Manifestasi klinis gejala kengesti hidung 63.3%, drainase mukopurulen 36.7%, sakit kepala 26.7%, gangguan penghidu 10%, nyeri wajah 6.7%./ Chronic rhinosinusitis is inflammation of the nose and paranasal sinuses lasting at least 8-12 weeks with more than 2 accompanying symptoms such as nasal congestion/obstruction/congestion, nasal discharge (anterior/posterior nasal drip), facial pain/pressure, and reduction or loss of smell as well as endoscopic signs of disease or relevant changes in Computerized Tomography Scan (CT Scan). According to the Global Allergy and European Network project (GA2LEN), the overall prevalence of CRS according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) criteria is 10.9% associated with asthma, especially late-onset. Several other studies were also carried out by SSR. A survey in the USA estimates that about 16% of the population is affected by CRS. The purpose of the study was to determine the prevalence of chronic rhinosinusitis in the THT-KL Polyclinic, Indonesian Christian University Hospital, Jakarta, for the 2018-2021 period. This study used a descriptive method with a retrospective design on 30 patients. The result is the majority of patients in the age group 30-39 years 30%, female gender 56.7%, and male 43.3%. Clinical manifestations were nasal congestion 63.3%, mucopurulent drainage 36.7%, headache 26.7%, olfactory disturbances 10%, facial pain 6.7%.

Actions (login required)

View Item